Publication | Closed Access

A personalized paradigm in the treatment of platinum-resistant ovarian cancer – A cost utility analysis of genomic-based versus cytotoxic therapy

MedicineCost Utility AnalysisCancer ManagementClinical TrialsGynecologyCancer GenomicsPersonalized ParadigmPlatinum-resistant Ovarian CancerCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian CancerHealth Sciences